Findings

What do systematic reviews say?

3 questions · 3 findings · 3 reviews · Gut

No studies found 1 · 33.3%GRADE not reported 0 · 0%Very low 0 · 0%Low 2 · 66.7%Moderate 0 · 0%High 0 · 0%

Withdrawals due to adverse events · Patients with collagenous colitis

Mesalamine showed no clear difference in withdrawals due to adverse events compared with placebo (low certainty).

1 finding from 1 review

Interventions for treating collagenous colitis 2017 · Cochrane Headline outcomes only
RR 5.92 [0.7, 49.9]
1 study · 62 participants
Low

Withdrawals due to adverse events · Participants with Crohn's disease in remission

The review found no eligible studies for this question.

1 finding from 1 review

Enteral nutrition for maintenance of remission in Crohn's disease 2018 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Withdrawals due to adverse events · Patients with active Crohn's disease

Budesonide 9 mg showed no clear difference in withdrawal due to adverse events compared with mesalamine (low certainty).

1 finding from 1 review

Budesonide for induction of remission in Crohn's disease 2015 · Cochrane Headline outcomes only
RR 0.43 [0.18, 1.03]
2 studies · 489 participants
Low